Oragenics's market cap is currently ―. The company's EPS TTM is $-7.903; its P/E ratio is -0.15; Oragenics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 7.47K	$ 13.16K	$ 17.02K	-	$ 0.00
Gross Profit	$ 7.47K	$ 13.16K	$ 17.02K	-	-
EBIT	$ -2.00M	$ -3.05M	$ -2.84M	$ -360.17K	$ -3.91M
EBITDA	$ -1.99M	$ -3.04M	$ -2.83M	$ -404.83K	$ -3.90M
Net Income Common Stockholders	$ -2.01M	$ -3.05M	$ 3.00M	$ -302.66K	$ -3.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.77M	$ 6.47M	$ 9.16M	$ 11.43M	$ 13.95M
Total Assets	$ 7.90M	$ 8.46M	$ 12.02M	$ 14.76M	$ 15.04M
Total Debt	$ 517.76K	$ 255.99K	$ 414.54K	$ 624.53K	$ 831.49K
Net Debt	$ -5.25M	$ -6.22M	$ -8.74M	$ -10.80M	$ -13.12M
Total Liabilities	$ 1.40M	$ 1.21M	$ 1.89M	$ 1.75M	$ 1.70M
Stockholders Equity	$ 6.50M	$ 7.26M	$ 10.24M	$ 13.01M	$ 13.34M
Cash Flow	-
Free Cash Flow	$ -1.44M	$ -2.63M	$ -2.06M	$ -2.44M	$ -3.81M
Operating Cash Flow	$ -1.50M	$ -2.63M	$ -2.06M	$ -2.43M	$ -3.78M
Investing Cash Flow	$ 63.72K	-	-	$ -3.44K	$ -37.03K
Financing Cash Flow	$ 732.12K	$ -107.89K	$ -159.75K	$ -88.00K	$ -103.50K

Currency in USD

Oragenics Earnings and Revenue History

Income Statement >

Oragenics Debt to Assets

Balance Sheet >

Oragenics Cash Flow

Cash Flow >

Oragenics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing